Microfluidic Platform for Continuous Production of Composite Microfibers with Precisely Aligned Embedded Microcompartments
This technology uses microfluidic devices to continuously create fibers with regularly spaced, customizable droplets inside, allowing precise encapsulation and release of drugs, cells, or particles for advanced biomedical and materials applications.
Background
The field of advanced fiber fabrication has seen significant growth due to the increasing demand for multifunctional materials in biomedical engineering, drug delivery, and smart materials. Traditional fibers, while useful for structural and some functional applications, often lack the ability to precisely compartmentalize and spatially organize multiple chemical or biological cargos within a single structure. This capability is crucial for applications such as controlled drug release, tissue scaffolding, and the creation of responsive materials that require the co-localization or sequential delivery of distinct agents. As the complexity of biomedical and materials science challenges grows, so does the need for fiber-based platforms that can integrate and spatially pattern diverse functionalities at the microscale.
Current approaches to producing composite fibers with internal compartments—such as electrospinning, bulk emulsification, and conventional microfluidic techniques—face significant limitations. Electrospinning, for example, typically yields fibers with random or poorly controlled internal structures, making it difficult to achieve regular, ordered compartmentalization. Bulk emulsification methods often result in heterogeneous dispersions of droplets within fibers, lacking spatial precision and reproducibility. Even existing microfluidic methods struggle with scalability, robust compartment alignment, and the ability to co-encapsulate cargos with incompatible solubilities or physical states. These shortcomings hinder the development of fibers with tailored release profiles, spatially resolved functionalities, and the ability to encode production sequence information—features that are increasingly essential for next-generation biomedical and smart material applications.
Technology
This technology is a microfluidic platform for the continuous production of composite microfibers that contain regularly aligned, embedded microcompartments formed from single or double emulsion droplets. Fabrication occurs within polydimethylsiloxane (PDMS) channels, where selective surface wettability modifications enable the stable generation of droplets using flow-focusing or T-junction modules. The process involves the solidification of a continuous polymer phase—commonly via ionic crosslinking, photochemistry, or solvent extraction—while maintaining the spatial order and spacing of the internal droplets. By precisely modulating flow rates and channel geometries, the system allows for fine control over the dimensions and density of the microenvironments within the fiber. These compartments can encapsulate a wide range of cargos, such as cells, nanoparticles, proteins, magnetic particles, or drugs, and the fibers themselves can be engineered from hydrogels or biodegradable polyesters, supporting applications in drug delivery, tissue engineering, and smart materials.
What differentiates this technology is its ability to create fibers with highly ordered, customizable multicompartment structures in a continuous and scalable manner, overcoming the limitations of traditional fiber fabrication and bulk emulsification methods. Unlike previous approaches that often yield random or poorly controlled compartmentalization, this microfluidic method preserves the temporal and spatial sequence of droplet formation, enabling precise patterning and co-encapsulation of multiple, even chemically incompatible, cargos. The modularity of the device design allows for systematic adjustment of compartment size, number, and spacing, as well as the integration of various chemistries and functionalities. Demonstrated capabilities include the encapsulation of viable cells, programmable drug release, magnetic manipulation, and selective compartment dissolution, making the platform uniquely suited for advanced biomedical and materials science applications that require spatially resolved, multifunctional fiber architectures.
Benefits
- Precise spatial control of embedded microcompartments within continuous microfibers
- Capability to co-encapsulate diverse cargos including drugs, nanoparticles, proteins, and living cells
- Continuous, scalable microfluidic fabrication process with tunable compartment size, spacing, and fiber diameter
- Versatile solidification methods (ionic crosslinking, photochemistry, solvent extraction) enabling varied fiber materials
- Modular device design allowing generation of single or double emulsion droplets and complex hierarchical structures
- Supports multifunctional applications such as controlled drug release, tissue engineering scaffolds, and magnetically responsive materials
- Selective dissolution of compartments enabling controlled release and sequential delivery
- High viability and functional maintenance of encapsulated cells within fibers for biomedical use
Applications
- Targeted drug delivery fibers
- Tissue engineering scaffolds
- Encapsulation of living cells
- Smart materials with programmable release
- Magnetically responsive fiber actuators
Additional info
This microfluidic platform continuously fabricates hydrogel microfibers featuring a solid polymer sheath with regularly aligned, embedded microcompartments. Utilizing selective surface wettability in PDMS channels, the process generates stable single or double emulsion droplets via flow-focusing modules. Solidification occurs through ionic crosslinking or photochemistry, preserving spatial order. Precise control of flow rates and geometry dictates compartment density, enabling co-encapsulation of diverse cargos like cells and drugs.